Literature DB >> 25556481

The polymorphism of hypoxia-inducible factor-1a gene in endometrial cancer.

Leila Kafshdooz1, Ali Dastranj Tabrizi, Seyyed Mojtaba Mohaddes, Tayebeh Kafshdooz, Abolfazl Akbarzadeh, Morteza Ghojazadeh, Jalal Gharesouran.   

Abstract

BACKGROUND: Endometral carcinoma is the most common malignant tumor of the female genital tract and the fourth most common cancer in women after breast, colorectal and lung cancers Hypoxia-inducible factor -1 (HIF-1) is a key transcription factor that regulates cellular response to hypoxia HIF-1 plays important roles in the development and progression of cancer through activation of various genes that are involved in crucial aspects of cancer biology, including angiogenesis, energy metabolism, vasomotor function, erythropoiesis, and cell survival. In this study, we aimed to investigate the association between HIF-1 1772 C/T polymorphisms and endometrial cancer.
MATERIALS AND METHODS: 75 patients with endometrial carcinoma and 75 patients whose underwent hysterectomy for non tumoral indication selected for evaluation of HIF-1 1772 C/T polymorphisms by PCR-RFLP and sequencing.
RESULTS: For the 1772 C/T polymorphism, the analysis showed that the T allele and genotype TT were significantly associated with endometrial cancer risk.
CONCLUSIONS: Our results suggest that the C1772T polymorphism of the HIF-1a may be associated with endometrial cancers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25556481     DOI: 10.7314/apjcp.2014.15.23.10393

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  2 in total

Review 1.  Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance.

Authors:  Łukasz Zadka; Damian J Grybowski; Piotr Dzięgiel
Journal:  Cell Oncol (Dordr)       Date:  2020-06-02       Impact factor: 6.730

2.  Effects of Tra2-beta1 on proliferation, apoptosis, and metastasis of hypoxic endometrial carcinoma cell and its correlation with clinicopathological features.

Authors:  Wenhuizi Sun; Dhruba Paudel; Sirui Song; Kewei Chen; Zhanqi Zhao; Lei Chu; Yiqin Ouyang
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.